Research output per year
Research output per year
Personal profile
Fingerprint
Dive into the research topics where Jakob Riedl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators.
Fece de la Cruz, F., Varkaris, A., Patel, P., Kushner, E., Morales-Giron, A., Lee, S., Singh, A., Kim, C., Norden, B., Ehnstrom, S., Riedl, J., Curtis, J., Barnes, H., Kehlmann, A., Chevalier, N., Okuma, H., Patel, M., Wirth, L., Connell, B. & Nugent, F. & 9 others, , 1 Apr 2026, In: Cancer Discovery. 16, 4, p. 677-685 9 p.Research output: Contribution to journal › Research article
5 Citations (Web of Science) -
Bridging the gap: targeted treatment strategies for cancer of unknown primary
Edlinger, L. (First author), Egger, V. & Riedl, J., 2026, In: Memo - Magazine of European Medical Oncology. 19, 1, 4 p.Research output: Contribution to journal › Review
-
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study.
Moik, F. (First author), Huemer, F., Doleschal, B., Taghizadeh, H., Reimann, P., Kostmann, S. M., Wagner, L., Abdel, H., Zimmer, K., Suppé, S., Bachleitner, C., Schaberl-Moser, R., Amann, A., Wolf, D., Greil, R., Jost, P., Winder, T., Rumpold, H., Weiss, L. & Gerger, A. & 2 others, , Apr 2026, In: ESMO Open. 11, 4, p. 106907 10 p., 106907.Research output: Contribution to journal › Research article
-
Emerging landscape of KRAS inhibitors in cancer treatment.
Riedl, J. (First author), Matsubara, H., McNeil, R., Patel, P., Fece de la Cruz, F., Gulhan, D. & Corcoran, R., 9 Mar 2026, In: Cancer Cell. 44, 3, p. 471-497 27 p.Research output: Contribution to journal › Review
14 Citations (Web of Science) -
MRi prostate tumor volume predicts the need for systematic biopsies in patients undergoing MRi-targeted biopsy
Zurl, H. (First author), Embacher, S., Schollnast, H., Talakic, E., Schopfer-Schwab, S., Pohl, K., Scheipner, L., Jasarevic, S., Altziebler, J., Mangge, A., Mannweiler, S., Riedl, J., Bele, U., Leitsmann, C., Leitsmann, M., Hutterer, G., Ahyai, S. & Mischinger, J. (Last author), Apr 2026, In: Minerva Urology and Nephrology. 78, 2, p. 222-231 10 p.Research output: Contribution to journal › Research article
-
Unlocking Regorafenib Response: A Novel Genomic and Transcriptomic Model for Metastatic Colorectal Cancer
Hamid, M. (Author), Pammer, L. (Author), Amann, A. (Author), Sweeney, K. (Author), Elliott, A. (Author), Tymoszuk, P. (Author), Nocera, F. (Author), Lenz, H. (Author), Gruber, R. (Author), Kocher, F. (Author), Huemer, F. (Author), Doleschal, B. (Author), Taghizadeh, H. (Author), Riedl, J. (Author), Wolf, D. (Author) & Seeber, A. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Low-level variants present a challenge in the clinical interpretation of liquid-biopsy-based comprehensive genomic profiling for patients with solid tumors.
Jonas, K. (Speaker), Riedl, J. (Author), Steinlechner, S. (Author), Moik, F. (Author), Jahn, S. (Author), Hasenleithner, S. (Author), Doleschal, B. (Author), Weiss, L. (Author), Seeber, A. (Author), Rumpold, H. (Author), Winder, T. (Author), Greil, R. (Author), Höfler, G. (Author), Gerger, A. (Author), Jost, P. (Author) & Heitzer, E. (Author)
2025Activity: Talk, presentation or poster › Poster
-
530P Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study
Seeber, A. (Author), Huemer, F. (Author), Doleschal, B. (Author), Taghizadeh, H. (Author), Reimann, P. (Author), Moik, F. (Author), Kostmann, S. M. (Author), Wagner, L. (Author), Granitzer, L. (Author), Abdel Hamid, M. (Author), Bachleitner, C. (Author), Amann, A. (Author), Wolf, D. (Author), Greil, R. (Author), Jost, P. (Author), Winder, T. (Author), Rumpold, H. (Author), Weiss, L. (Author), Gerger, A. (Author) & Riedl, J. (Author)
2024Activity: Talk, presentation or poster › Poster
-
122P - Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
Moik, F. (Speaker), Riedl, J. (Author), Edlinger, L. (Author), Esterl, T. (Author), Hasenleithner, S. (Author), Kostmann, S. M. (Author), Cebular, L. (Author), Jahn, S. (Author), Kashofer, K. (Author), Zacharias, M. (Author), Hoefler, G. (Author), Heitzer, E. (Author), Gerger, A. (Author) & Jost, P. (Author)
2024Activity: Talk, presentation or poster › Poster
-
Low-level variants present a challenge in the clinical interpretation of liquid-biopsy-based comprehensive genomic profiling for patients with solid tumors
Jonas, K. (Speaker), Riedl, J. (Author), Steinlechner, S. (Author), Moik, F. (Author), Jahn, S. (Author), Hasenleitner, S. (Author), Doleschal, B. (Author), Weiss, L. (Author), Seeber, A. (Author), Rumpold, H. (Author), Winder, T. (Author), Greil, R. (Author), Höfler, G. (Author), Gerger, A. (Author), Jost, P. (Author) & Heitzer, E. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
Prizes
-
Ars Docendi Staatspreis für exzellente Lehre 2020
Zaufel, A. (Recipient), Kraler, S. (Recipient), Rosenkranz, A. (Recipient), Moik, F. (Recipient), Köller, M. (Recipient), Fickert, P. (Recipient), Stelzl, A. (Recipient), Riedl, J. (Recipient), Magomedov, A. (Recipient), Wenzl, F. (Recipient), Scheu, V. I. (Recipient), Weikl, S. (Recipient), Aliabadi, A. (Recipient), Mayer, G. (Recipient), Ehsas, H. (Recipient), Schreiber, N. (Recipient), Mady, S. (Recipient), Egger, M. F. (Recipient), Haider, C. (Recipient) & Schmalzer, F. (Recipient), 24 Sept 2020
Prize
-